Systemic Juvenile Idiopathic Arthritis and Secondary Macrophage Activation Syndrome in Latvia from 2009 to 2020: A Nationwide Retrospective Study

Conclusions: The incidence and clinical characteristics of sJIA correlate with the literature findings, although MAS was more common than described in other studies. There is a tendency for the persistent disease to decrease with the use of biological therapy. Tocilizumab is an efficient choice of treatment with a good safety profile.PMID:37109756 | PMC:PMC10144400 | DOI:10.3390/medicina59040798

Source: Medicina (Kaunas) - April 28, 2023 Category: Universities & Medical Training Authors: Krist īne Lukjanoviča Ieva Šlēziņa Zane D āvidsone Ruta Šantere Krist īna Budarina Valda Sta ņēviča Source Type: research